RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension

RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension

On June 23, 2020, we hosted an online RNAi Roundtable to review the progress with ALN-AGT, an RNAi therapeutic in development for the treatment of hypertension.

Access the replay

View the presentation

Read the transcript

John Maraganore, Ph.D.
Chief Executive Officer

Akshay Desai, M.D., M.P.H.
Director, Cardiomyopathy and Heart Failure Program, Cardiovascular Division, Brigham and Women’s Hospital;
Associate Professor of Medicine, Harvard Medical School

Jae Kim, M.D.
Vice President, Clinical Development

Lauren Melton
Senior Director, Program Leader, ALN-AGT



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.